Healthcare >> CEO Interviews >> November 1, 1999
JAMES L. VINCENT is Chairman of the Board and CEO of Biogen, Inc.
Biogen, formed in 1978, is one of the leading biopharmaceutical
companies in the world. He formerly served as President of Allied Health
and Scientific Products Company, a subsidiary of Allied/Signal
Corporation. Prior to Allied, Mr. Vincent was with Abbott Laboratories
(Chief Operating Officer and Board Member) where he was also the
Founding President of Abbott's Diagnostics business. Before Abbott, he
was with Texas Instruments in Europe and Japan (President, T.I. Asia).
Mr. Vincent is a member of the Massachusetts Business Roundtable and
Economic club of Chicago. He is a member of the Boards of CuraGen
Corporation, the Pharmaceutical Research and Manufacturers of America
(PhARMA), Committee for Economic Development and the Multiple Sclerosis
Society (Massachusetts Chapter), and on the Board of Trustees of Duke
University as well as a member of The Wharton School's Board of
Overseers. Mr. Vincent was selected by Industry Week Magazine as one of
the top 15 industrial CEO's in America, New England Business Magazine
named him Businessperson of the Year, and in 1996, he received the Wall
Street Transcript Gold Award for the biotechnology industry. He was
awarded an honorary Doctor of Business Administration from the
University of New Haven in May of 1998. Mr. Vincent received his
Bachelor of Science in Mechanical Engineering from Duke University and
Master of Business Administration from Wharton Graduate Business School,
University of Pennsylvania. Profile
Then tell us what you see as your business and company today?
Mr. Vincent: Biogen, from a historical perspective, is
